{"cited_by_count":3363263,"description":"This cluster of papers focuses on the diagnosis, pathogenesis, and treatment of multiple sclerosis (MS) and related disorders such as neuromyelitis optica. It covers topics such as the diagnostic criteria for MS, genetic risk factors, immune mechanisms involved in MS, cognitive impairment, axonal injury, and the autoimmune pathology underlying the disease. The papers also discuss the use of various therapies and their effects on MS patients.","display_name":"Multiple Sclerosis Research Studies","domain_id":"4","external_ids":{"openalex":"https://openalex.org/T10137","wikipedia":"https://en.wikipedia.org/wiki/Multiple_sclerosis"},"field_id":"27","id":"T10137","keywords":[{"display_name":"multiple sclerosis","id":"multiple-sclerosis","score":0.6076,"url":"https://openalex.org/keywords/multiple-sclerosis"},{"display_name":"relapsing-remitting multiple sclerosis","id":"relapsing-remitting-multiple-sclerosis","score":0.8502,"url":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis"},{"display_name":"demyelination","id":"demyelination","score":0.4485,"url":"https://openalex.org/keywords/demyelination"},{"display_name":"experimental autoimmune encephalomyelitis","id":"experimental-autoimmune-encephalomyelitis","score":0.6572,"url":"https://openalex.org/keywords/experimental-autoimmune-encephalomyelitis"},{"display_name":"disease-modifying therapy","id":"disease-modifying-therapy","score":0.4362,"url":"https://openalex.org/keywords/disease-modifying-therapy"},{"display_name":"disability progression","id":"disability-progression","score":0.8718,"url":"https://openalex.org/keywords/disability-progression"},{"display_name":"demyelinating disease","id":"demyelinating-disorders","score":0.5576,"url":"https://openalex.org/keywords/demyelinating-disorders"},{"display_name":"Expanded Disability Status Scale","id":"expanded-disability-status-scale","score":0.8552,"url":"https://openalex.org/keywords/expanded-disability-status-scale"},{"display_name":"optic neuritis","id":"optic-neuritis","score":0.5301,"url":"https://openalex.org/keywords/optic-neuritis"},{"display_name":"neuromyelitis optica spectrum disorder","id":"neuromyelitis-optica-spectrum-disorder","score":0.8031,"url":"https://openalex.org/keywords/neuromyelitis-optica-spectrum-disorder"},{"display_name":"secondary progressive multiple sclerosis","id":"secondary-progressive-multiple-sclerosis","score":0.8918,"url":"https://openalex.org/keywords/secondary-progressive-multiple-sclerosis"},{"display_name":"neuromyelitis optica","id":"neuromyelitis-optica","score":0.7513,"url":"https://openalex.org/keywords/neuromyelitis-optica"},{"display_name":"remyelination","id":"remyelination","score":0.4393,"url":"https://openalex.org/keywords/remyelination"},{"display_name":"interferon-beta","id":"interferon-beta","score":0.2131,"url":"https://openalex.org/keywords/interferon-beta"},{"display_name":"myelin basic protein","id":"myelin-basic-protein","score":0.3501,"url":"https://openalex.org/keywords/myelin-basic-protein"},{"display_name":"aquaporin-4 antibodies","id":"aquaporin-4-antibodies","score":0.8447,"url":"https://openalex.org/keywords/aquaporin-4-antibodies"},{"display_name":"primary progressive multiple sclerosis","id":"primary-progressive-multiple-sclerosis","score":0.8872,"url":"https://openalex.org/keywords/primary-progressive-multiple-sclerosis"},{"display_name":"natalizumab","id":"natalizumab","score":0.5355,"url":"https://openalex.org/keywords/natalizumab"},{"display_name":"relapse rate","id":"relapse-rate","score":0.4329,"url":"https://openalex.org/keywords/relapse-rate"},{"display_name":"fingolimod","id":"fingolimod","score":0.3902,"url":"https://openalex.org/keywords/fingolimod"},{"display_name":"clinically isolated syndrome","id":"clinically-isolated-syndrome","score":0.8949,"url":"https://openalex.org/keywords/clinically-isolated-syndrome"},{"display_name":"glatiramer acetate","id":"glatiramer-acetate","score":0.7355,"url":"https://openalex.org/keywords/glatiramer-acetate"},{"display_name":"acute disseminated encephalomyelitis","id":"acute-disseminated-encephalomyelitis","score":0.6054,"url":"https://openalex.org/keywords/acute-disseminated-encephalomyelitis"},{"display_name":"progressive multiple sclerosis","id":"progressive-multiple-sclerosis","score":0.8793,"url":"https://openalex.org/keywords/progressive-multiple-sclerosis"},{"display_name":"myelin oligodendrocyte glycoprotein","id":"myelin-oligodendrocyte-glycoprotein","score":0.6687,"url":"https://openalex.org/keywords/myelin-oligodendrocyte-glycoprotein"}],"legacy_keywords":["Multiple Sclerosis","Diagnostic Criteria","Neuromyelitis Optica","Demyelination","Immune Mechanisms","Genetic Risk","B-Cell Depletion","Cognitive Impairment","Axonal Injury","Autoimmune Pathology"],"openalex_id":"https://openalex.org/T10137","source_created_date":"2024-01-23T15:27:05","source_updated_date":"2026-10-17T03:02:00","subfield_id":"2734","url":"/topics/T10137","works_api_url":"https://api.openalex.org/works?filter=topics.id:T10137","works_count":183961,"label":"Multiple Sclerosis Research Studies","provider":"openalex","revision":"e318b1a8b3db90f2","taxonomy_revision":"f050b5d4780b1289","title":"Multiple Sclerosis Research Studies","kind":"topic-directory","aeo_cohort":"topic-directory","catalogue_revision":"f050b5d4780b1289","numeric_address":"36108824075756906","address_version":"morton4x16-v1","coordinates":[4,27,2734,10137],"answer_status":"Directory metadata; local answer requires separate source review","truth_status":"Subject descriptor, not a factual answer or a demonstrated knowledge gap","reviewed_answer":null}